Home > Boards > US Listed > Biotechs > Allergan (AGN)

This board is a stub.

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
DewDiligence Member Profile
Member Level 
Followed By 724
Posts 109,657
Boards Moderated 15
Alias Born 09/05/02
160x600 placeholder
Davidson Kempner Capital Management LP Davidson Kempner Capital Management Lp : Form 8.3 - Allergan Plc Dow Jones News - 11/19/2019 10:50:00 AM
Form 8.3 - [AbbVie Inc.] Dow Jones News - 11/19/2019 9:48:00 AM
Davidson Kempner Capital Management LP Davidson Kempner Capital Management Lp : Form 8.3 - Allergan Plc Dow Jones News - 11/18/2019 10:50:00 AM
Form 8.3 - [AbbVie Inc.] Dow Jones News - 11/18/2019 9:45:00 AM
Allergan® Announces First Annual National BOTOX® Cosmetic (onabotulinumtoxinA) Day PR Newswire (US) - 11/18/2019 7:30:00 AM
Davidson Kempner Capital Management LP Davidson Kempner Capital Management Lp : Form 8.3 - Allergan Plc Dow Jones News - 11/15/2019 10:50:00 AM
Form 8.3 - [AbbVie Inc.] Dow Jones News - 11/15/2019 9:39:00 AM
Davidson Kempner Capital Management LP Davidson Kempner Capital Management Lp : Form 8.3 - Allergan Plc Dow Jones News - 11/14/2019 10:50:00 AM
Form 8.3 - [Abbvie. Inc] Dow Jones News - 11/14/2019 9:46:00 AM
Exicure and Allergan Agree to Develop Hair-Loss Treatment Dow Jones News - 11/14/2019 7:56:00 AM
Credit Markets: AbbVie's $30 Billion Sale of Debt Draws Strong Demand -- WSJ Dow Jones News - 11/13/2019 3:02:00 AM
AbbVie Sells $30 Billion of Bonds -- 2nd Update Dow Jones News - 11/12/2019 6:39:00 PM
AbbVie Prepares Large Bond Sale -- Update Dow Jones News - 11/12/2019 3:34:00 PM
AbbVie Prepares Large Bond Sale to Fund Allergan Purchase Dow Jones News - 11/12/2019 1:32:00 PM
Allergan Gets FDA Fast-Track, Qualified Infectious Disease Status for ATM-AVI Dow Jones News - 11/11/2019 8:20:00 AM
Allergan Receives FDA Qualified Infectious Disease Product (QIDP) Designation And Fast Track Designation For ATM-AVI (Aztreon... PR Newswire (US) - 11/11/2019 7:30:00 AM
Patients Sue Breast-Implant Manufacturer Allergan, Says Consumer-Rights Law Firm FeganScott Business Wire - 11/8/2019 5:48:00 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 11/5/2019 5:04:03 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/5/2019 8:12:06 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/5/2019 7:18:11 AM
Allergan Reports Third Quarter 2019 Financial Results PR Newswire (US) - 11/5/2019 7:00:00 AM
FDA Approves Medicines360's LILETTA® (levonorgestrel-releasing intrauterine system) 52 mg to Prevent Pregnancy for up to Six... PR Newswire (US) - 10/28/2019 9:00:00 AM
Forest Resolves Antitrust Class Action Litigation with Direct Purchasers of Namenda PR Newswire (US) - 10/28/2019 8:31:00 AM
AbbVie Announces Commencement of Exchange Offers and Consent Solicitations for Allergan Notes PR Newswire (US) - 10/25/2019 8:11:00 AM
Allergan Declares Fourth Quarter 2019 Cash Dividend of $0.74 Per Ordinary Share PR Newswire (US) - 10/25/2019 7:00:00 AM
DewDiligence Member Level  Monday, 06/15/15 08:55:06 AM
Re: None
Post # of 103 
This board is a stub.

Actavis, the company who acquired the original AGN in Mar 2015, has renamed itself Allergan and begins trading today with the AGN ticker symbol:

http://finance.yahoo.com/news/actavis-plc-now-allergan-plc-110000618.html

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”
Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist